Predisposing factors to post-operative adhesion development

Human Reproduction Update

Volumn 21, Issue 4, 2014, Pages 536-551

  Fortin, Chelsea N ^a   Saed, Ghassan M ^b   Diamond, Michael P ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Fibrosis; Hemostasis; Hypoxia; Post operative adhesions; Predisposing factors

Indexed keywords

ANTIPARKINSON AGENT; ATORVASTATIN; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEVODOPA; MEVINOLIN; MIFEPRISTONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIMVASTATIN; TAMOXIFEN CITRATE; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; IL1RN PROTEIN, HUMAN; SERPINE1 PROTEIN, HUMAN;

ABDOMINAL SURGERY; AGE DISTRIBUTION; ALCOHOL ABUSE; ARTICLE; BLOOD CLOTTING; COLORECTAL SURGERY; DEPRESSION; DIABETES MELLITUS; DIET; DISEASE PREDISPOSITION; ENDOMETRIOSIS; EXERCISE; FIBROSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GYNECOLOGIC SURGERY; HORMONAL THERAPY; HUMAN; HYPERGLYCEMIA; MENSTRUAL CYCLE; METABOLIC SYNDROME X; MOOD; NEOPLASM; NONHUMAN; OBESITY; PELVIS SURGERY; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; STRESS; SYSTEMATIC REVIEW; TISSUE ADHESION; ABDOMEN; ANTIBODY SPECIFICITY; COMPLICATION; FEMALE; GENETICS; METABOLISM; PELVIS; POSTOPERATIVE COMPLICATIONS; SINGLE NUCLEOTIDE POLYMORPHISM; SURGERY; TISSUE ADHESIONS;

ABDOMEN; CARBOXYPEPTIDASE B2; ENDOMETRIOSIS; ESTROGENS; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; ORGAN SPECIFICITY; PELVIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; TISSUE ADHESIONS;

EID: 84938521271     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmv021     Document Type: Article

References (237)

1. Aarons CB, Cohen PA, Gower A, Reed KL, Leeman SE, Stucchi AF, Becker JM. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg 2007;2:176-184.
2. Achiron R, Lipitz S, Frenkel Y, Mashiach S. Endometrial blood flowresponse to estrogen replacement therapy and tamoxifen in asymptomatic, postmenopausal women: a transvaginal Doppler study. Ultrasound Obstet Gynecol 1995;6:411-414.
3. Adzick NS, Harrison MR, Glick PL, Beckstead JH, Villa RL, Scheuenstuhl H, Goodson WH III. Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J Pediatr Surg 1985;4:315-319.
4. Ahn C, Mulligan P, Salcido RS. Smoking-the bane of wound healing: biomedical interventions and social influences. Adv Skin Wound Care 2008;21:227-236.
5. Aleem FA, Predanic M. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography. Gynecol Endocrinol 1995;3:253-258.
6. Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008;99:995-1000.
7. Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol 2003;23:1262-1268.
8. Allen RA, Kluft C, Brommer EJ. Effect of chronic smoking on fibrinolysis. Arteriosclerosis 1985;5:443-450.
9. Alpay Z, Ozgonenel M, Savasan S, Buck S, Saed GM, Diamond MP. Altered in vitro immune response to hypoxia-treated normal peritoneal fibroblasts. Fertil Steril 2007;2:426-429.
10. Alpay Z, Saed GM, Diamond MP. Postoperative adhesions: from formation to prevention. Semin Reprod Med 2008;26:313-321.
11. Ambler DR, Golden AM, Gell JS, Saed GM, Carey DJ, Diamond MP. Microarray expression profiling in adhesion and normal peritoneal tissues. Fertil Steril 2012; 97:1158-1164.e1-4.
12. Anaya DA, Dellinger EP. The obese surgical patient: a susceptible host for infection. Surg Infect (Larchmt) 2006;7:473-480.
13. Ara C, Kirimlioglu H, Karabulut AB, Coban S, Kascalik S, Celik O, Yilmaz S, Kirimliogly V. Protective effect of melatonin against oxidative stress on adhesion formation in the rat cecum and uterine horn model. Life Sci 2005;12:1341-1350.
14. Ariens RAS, de Lange M, Snieder H, Boothby M, Spector TD, Grant PJ. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet 2002;9307:667-671.
15. Awonuga AO, Fletcher NM, Saed GM, Diamond MP. Postoperative adhesion development following cesarean and open intra-abdominal gynecological operations: a review. Reprod Sci 2011;12:1-20.
16. Balagopal P, George D, Sweeten S, Mann KJ, Yarandi H, Mauras N, Vaughan DE. Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children. J Thromb Haemost 2008;6:1296-1303.
17. Barcz E, Milewski Ł, Dziunycz P, Kamiński P, Płoski R, Malejczyk J. Peritoneal cytokines and adhesion formation in endometriosis: an inverse association with vascular endothelial growth factor concentration. Fertil Steril 2012;6:1380-6.e1.
18. Beck DE. The role of seprafilm bioresorbable membrane in adhesion prevention. Eur J Surg Suppl 1997;577:49-55.
19. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou JP, Scarabin PY, Bara L, Green F et al. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation 1996;3:440-449.
20. Biggs R, MacFarland RG, Pilling J. Observations on fibrinolysis: experimental activity produced by exercise or adrenaline. Lancet 1947;6448:402-405.
21. Boffa MB, Reid TS, Joo E, Nesheim ME, Koschinsky ML. Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). Biochemistry 1999;38:6547-6558.
22. Braun N, Alscher MD, Kimmel M, Amann K, Büttner M. Encapsulating peritoneal sclerosis-an overview. Nephrol Ther 2011;7:162-171.
23. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007;117:1219-1222.
24. Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004;114:409-414.
25. Bristow RE, Montz FJ. Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier. Gynecol Oncol 2005;99:301-308.
26. Bruse C, Radu D, Bergqvist A. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue. Mol Hum Reprod 2004;10:159-166.
27. Burrington JD. Wound healing in the fetal lamb. J Pediatr Surg 1971;5:523-528.
28. Callejon DR, Franceschini SA, Montes MB, Toloi MR. Hormone replacement therapy and hemostasis: effects in Brazilian postmenopausal women. Maturitas 2005;52:249-255.
29. Cates W, Farley TM, Rowe PJ. Worldwide patterns of infertility: is Africa different? Lancet 1985;2:596-598.
30. Cesari M, Sartori MT, Patrassi GM, Vettore S, Rossi GP. Determinants of plasma levels of plasminogen activator inhibitor-1: a study of normotensive twins. Arterioscler Thromb Vasc Biol 1999;2:316-320.
31. Chan LK, Withey S, Butler PE. Smoking and wound healing problems in reduction mammaplasty: is the introduction of urine nicotine testing justified? Ann Plast Surg 2006;56:111-115.
32. Charles MA, Morange P, Eschwege E, Andre P, Vague P, Juhan-Vague I. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Diabetes Care 1998;21:1967-1972.
33. Cheong YC, Laird TCL, Shelton JB, Ledger WL, Cooke ID. Peritoneal healing and adhesion formation/reformation. Hum Reprod Update 2001;6:556-566.
34. Cheong YC, Reading I, Bailey S, Sadek K, Ledger W, Li TC. Should women with chronic pelvic pain have adhesiolysis? BMC Womens Health 2014;14:36.
35. Chia S, Newby DE. Atherosclerosis, cigarette smoking, and endogenous fibrinolysis: is there a direct link? Curr Atheroscler Rep 2002;2:143-148.
36. Chung HC, Rha SY, Park JO, Yoo NC, Kim JH, Roh JK, Min JS, Lee KS, Kim BS, Kim JJ. Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients. Breast Cancer Res Treat 1998;49:41-50.
37. Cigolini M, Targher G, Agostino G, Tonoli M, Muggeo M, De Sandre G. Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men-role of the metabolic syndrome. Thromb Haemost 1996;76:69-73.
38. Clarke-Pearson DL, Soper JT, Creasman WT. Absorbable synthetic mesh (polyglactin 910) for the formation of a pelvic 'lid' after radical pelvic resection. Am J Obstet Gynecol 1988;1:158-161.
39. Coddington CC, Grow DR, Ahmed MS, Toner JP, Cook E, Diamond MP. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertil Steril 2009;5:1909-1913.
40. Collen D. On the regulation and control of fibrinolysis. Thromb Haemost 1980; 43:77-89.
41. Cosman F, Baz-Hecht M, Cushman M, Vardy MD, Cruz JD, Nieves JW, Zion M, Lindsay R. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thromb Res 2005;116:1-13.
42. Davey AK, Maher PJ. Surgical adhesions: a timely update, a great challenge for the future. J Minim Invasive Gynecol 2007;1:15-22.
43. Davis MC, Swan PD. Association of negative and positive social ties with fibrinogen levels in young women. Health Psychol 1999;18:131-139.
44. Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 1991;11:183-190.
45. Dedrick RL, Myers CE, Bungay PM, DeVita VT. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 1978;1:1-11.
46. de Lange M, Snieder H, Ariens R, Spector T, Grant PJ. The genetics of haemostasis: a twin study. Lancet 2001;357:101-105.
47. de Mello VD, Kolehmainen M, Schwab U, Mager U, Laaksonen DE, Pulkkinen L, Niskanen L, Gylling H, Atalay M, Rauramaa R et al. Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. Metabolism 2008;57:192-199.
48. Dentino AN, Pieper F, Rao MK, Currie MS, Harris T, Blazer DG, Cohen HJ. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 1999;47:6-11.
49. de Sousa E, del Peso-Gilsanz G, Bajo-Rubio MA, Ossorio-González M, Selgas-Gutiérrez R. Encapsulating peritoneal sclerosis in peritoneal dialysis. a reviewand European initiative for approaching a serious and rare disease. Nefrologia 2012;32:707-714.
50. Desouza CA, Dengel DR, Rogers MA, Cox K, Macko RF. Fibrinolytic responses to acute physical activity in older hypertensive men. J Appl Physiol 1997;82:1765-1770.
51. Diamond MP. Prevention of adhesions. In: Gershenson DM, De Cherney AH, Curry SL (eds). Operative Gynecology. Philadelphia, PA:W.B. Saunders, 1993, 147-158.
52. Diamond MP. Reduction of adhesions after uterine myomectomy by seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm adhesion study group. Fertil Steril 1996;66:904-910.
53. Di Filippo C, Falsetto A, De Pascale V, Tufariello E, De Lucia D, Rossi F, D'Amico M, Cennamo A. Plasma levels of t-PA and PAI-1 correlate with the formation of experimental post-surgical peritoneal adhesions. Mediators Inflamm 2006;4:13901.
54. Dimmitt SB, Rakic V, Puddey IB, Baker R, Oostryck R, Adams MJ, Chesterman CN, Burke V, Beilin LJ. The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial. Blood Coagul Fibrinolysis 1998;9:39-45.
55. di Zerega GS. The cause and prevention of postsurgical adhesions: a contemporary update. Prog Clin Biol Res 1993;381:1-18.
56. di Zerega GS. Biochemical events in peritoneal tissue repair. Eur J Surg 1997;577:10-16.
57. Dong J, Fujii S, Goto D, Furumoto T, Kaneko T, Zaman TA, Nakai Y, Mishima T, Imagawa S, Kitabatake A. Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives. Hypertens Res 2003;26:723-729.
58. Dong J, Fujii S, Imagawa S, Matsumoto S, Matsushita M, Todo S, Tsutsui H, Sobel BE. IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPdelta. Am J Physiol Cell Physiol 2007;292:C209-C215.
59. Duffy DM, di Zerega GS. Adhesion controversies: pelvic pain as a cause of adhesions, crystalloids in preventing them. J Reprod Med 1996;1:19-26.
60. Dziunycz P, Milewski Ł, Radomski D, Barcz E, Kamiński P, Roszkowski PI, Malejczyk J. Elevated ghrelin levels in the peritoneal fluid of patients with endometriosis:associations with vascular endothelial growth factor (VEGF) and inflammatory cytokines. Fertil Steril 2009;6:1844-1849.
61. Edelstam G, Lecander I, Larsson B, Astedt B. Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease. Inflammation 1998;22:341-351.
62. Eliasson M, Asplund K, Evrin PE, Lundblad D. Relationship of cigarettesmoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin: The Northern Sweden MONICA Study. Artherosclerosis 1995;113:41-53.
63. Eliasson M, Asplund K, Evrin PE. Regular leisure time physical activity predicts high activity of tissue plasminogen activator: The Northern Sweden MONICA Study. Int J Epidemiol 1996;25:1182-1188.
64. Elkeles RS, Chakrabarti R, Vickers M, Stirling Y, Meade TW. Effect of treatment of hyperlipidaemia on haemostatic variables. BMJ 1980;281:973-974.
65. Ellis H. The cause and prevention of post-operative intraperitoneal adhesions. Surg Gynecol Obstet 1971;133:497-511.
66. Ellis H. The causes and prevention of intestinal adhesions. Br J Surg 1982;69:241-243.
67. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, McGuire A, Lower AM, Hawthorn RJ, O'Brien F et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 9163:1476-1480.
68. Erdogan E, Celayir S, Eroglu E, Yilmaz E. The relation between human leukocyte antigen (HLA) distribution and intestinal obstruction and adhesions in childhood:preliminary report. Pediatr Surg Int 2000;16:374-376.
69. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is association with myocardial infarction. Proc Natl Acad Sci USA 1995;92:1851-1855.
70. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-963.
71. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
72. Fevang BT, Fevang J, Stangeland L, Soreide O, Svanes K, Viste A. Complications and death after surgical treatment of small bowel obstruction: a 35-year institutional experience. Ann Surg 2000;4:529-537.
73. Fletcher NM, Jiang ZL, Diamond MP, Abu-Soud HM, Saed GM. Hypoxia-generated superoxide induces the development of the adhesion phenotype. Free Radic Biol Med 2008;45:530-536.
74. Fletcher NM, Abuanzeh S, Saed MG, Diamond MP, Abu-Soud HM, Saed GM. Nicotinamide adenine dinucleotide phosphate oxidase expression is differentially regulated to favor a pro-oxidant state that contributes to postoperative adhesion development. Reprod Sci 2014;21:1050-1059.
75. Fontana L, Eagon JC, Colonna M, Klein S. Impairedmononuclear cellimmune function in extreme obesity is corrected by weight loss. Rejuvenation Res 2007;10:41-46.
76. Friedlander Y, Elkana Y, Sinnreich R, Kark JD. Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutz family study. Am J Hum Genet 1995;56:1194-1206.
77. Frimerman A, Miller HI, Laniado S, Keren G. Changes in hemostatic function at times of cyclic variation in occupational stress. Am J Cardiol 1997;79:72-75.
78. Fruehauf JP, Meyskens FL. Reactive oxygen species: a breath of life or death? Clin Cancer Res 2007;3:789-794.
79. Giardina EG, Chen HJ, Sciacca RR, Rabbani LE. Dynamic variability of hemostatic and fibrinolytic factors in young women. J Clin Endocrinol Metab 2004;89:6179-6184.
80. Gilabert-Estelles J, Estelles A, Gilabert J, Castello R, Espana F, Falco C, Romeu A, Chirivella M, Zorio E, Aznar J. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 2003;18:1516-1522.
81. Gilabert-Estelles J, Castello R, Gilabert J, Ramon LA, Espana F, Romeu A, Estelles A. Plasminogen activators and plasminogen activator inhibitors in endometriosis. Front Biosci 2005;10:1162-1176.
82. Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med 2007; 262:157-172.
83. Green F, Hamsten A, Blomback M, Humphries S. The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993;70:915-920.
84. Grow DR, Coddington CC, Hsiu JG, Mikich Y, Hodgen GD. Role of hypoestrogenism or sex steroid antagonism in adhesion formation after myometrial surgery in primates. Fertil Steril 1996;1:140-147.
85. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res 2010;89:219-229.
86. Hamalainen H, Ronnemaa T, Virtanen A, Lindstrom J, Eriksson JG, Valle TT, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Rastas M, Aunola S et al. Improved fibrinolysis by an intensive lifestyle intervention in studies with impaired glucose tolerance. The Finnish Diabetes Prevention Study. Diabetologia 2005;48:2248-2253.
87. Hamilton JA, Leizer T, Lingelbach SR. The stimulation of human synovial fibroblast plasminogen activator activity. Involvement of cyclic AMP and cyclooxygenase products. Biochim Biophys Acta 1986;886:195-202.
88. Hamsten A, Iselius L, de Faire U, Blomback M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987;2:988-991.
89. Haslinger B, Kleemann R, Toet KH, Kooistra T. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int 2003;6:2065-2074.
90. Heinrich J, Funke H, Rust S, Schulte H, Schonfeld R, Kohler E, Assmann G. Impact of polymorphisms in the alpha-and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1995;77:209-215.
91. Hellebrekers BWJ, Kooistra T. Pathogenesis of postoperative adhesion formation. Br J Surg 2011;98:1503-1516.
92. Hellebrekers BW, Trimbos-Kemper TC, Boesten L, Jansen FW, Kolkman W, Trimbos JB, Press RR, van Poelgeest MI, Emeis SJ, Kooistra T. Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study. Fertil Steril 2009;4:1204-1214.
93. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003;29:125-130.
94. Hervé MA, Meduri G, Petit FG, Domet TS, Lazennec G, Mourah S, Perrot-Applanat M. Regulation of the vascular endothelial growth factor (VEGF) receptor flk-1/KDR by estradiol through VEGF in uterus. J Endocrinol 2006;1:91-99.
95. Holmdahl L. The role of fibrinolysis in adhesion formation. Eur J Surg 1997;(Suppl 577):24-31.
96. Hong Y, Pedersen NL, Egberg N, de Faire U. Moderate genetic influences onplasmalevels of plasminogen activator inhibitor-1 and evidence of genetic and environmental influences shared by plasminogen activator inhibitor-1, triglycerides, and body mass index. Arterioscler Thromb Vasc Biol 1997;11:2776-2782.
97. Hubbard SC, Burns JW. Effects of a hyaluronan-based membrane (Seprafilm) on intraperitoneally disseminated human colon cancer cell growth in a nude mouse model. Dis Colon Rectum 2002;45:334-341.
98. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; 1:1452-1455.
99. Iversen LH, Okholm M, Thorlacius-Ussing O. Pre-and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease-a preliminary study. Thromb Haemost 1996;76:523-528.
100. Ivey FM, Womack CJ, Kulaputana O, Dobrovolny CL, Wiley LA, Macko RF. A single bout of walking exercise enhances endogenous fibrinolysis in stroke patients. Med Sci Sports Exerc 2003;35:193-198.
101. Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989; 62:767-771.
102. Jiang ZL, Zhu X, Diamond MP, Abu-Soud HM, Saed GM. Nitric oxide synthase isoforms expression in fibroblasts isolated from human normal peritoneum and adhesion tissues. Fertil Steril 2008;3:769-774.
103. Jiang ZL, Fletcher NM, Diamond MP, Abu-Soud HM, Saed GM. Hypoxia regulates iNOS expression in human normal peritoneal and adhesion fibroblasts through nuclear factor kappa B activation mechanism. Fertil Steril 2009;2:616-621.
104. Johansen KM, Skorpe S, Olsen JO, Osterud B. The effect of red wine on the fibrinolytic system and the cellular activation reactions before and after exercise. Thromb Res 1999;96:355-363.
105. Juhan-Vague I, Alessi MC. Fibrinolysis and risk of coronary artery disease. Fibrinolysis 1996;10:127-136.
106. Juhan-Vague I, Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34:457-462.
107. Juhan-Vague I, Roul C, Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients-relationship with plasma insulin. Thromb Haemost 1989;61:370-373.
108. Karaca T, Gözalan AU, Yoldaş O, Bilgin BC, Tezer A. Effects of tamoxifen citrate on postoperative intra-abdominal adhesion in a rat model. Int J Surg 2013;1:68-72.
109. Kaye SM, Pietilainen KH, Kotronen A, Joutsi-Korhonen L, Kaprio J, Yki-Jarvinen H, Silveira A, Hamsten A, Lassila R, Rissanen A. Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs. Obesity 2012;1:88-94.
110. Knol HM, Kemperman RF, Kluin-Nelemans HC, Mulder AB, Meijer K. Haemostatic variables during normal menstrual cycle. A systematic review. Thromb Haemost 2012;1:22-29.
111. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, Mc-Burnie MA, Walston J, Newmann A, Hirsch C, Tracy RP. Inflammation and coagulation factors in persons. 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002;89:419-424.
112. Korte MR, Sampimon DE, Betjes MG, Krediet RT. Encapsulating peritoneal sclerosis:the state of affairs. Nat Rev Nephrol 2011a;7:528-538.
113. Korte MR, Sampimon DE, Lingsma HF, Fieren MW, Looman CW, Zietse R, Weimar W, Betjes MG. Dutch Multicenter EPS Study. Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study. Perit Dial Int 2011b;31:269-278.
114. Krummel TM, Nelson JM, Diegelmann RF, Lindblad WJ, Salzberg AM, Greenfield LJ, Cohen IK. Fetal response to injury in the rabbit. J Pediatr Surg 1987;7:640-644.
115. Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990;39:1044-1048.
116. Lassaletta AD, Chu LM, Sellke FW. Effects of alcohol on pericardial adhesion formation in hypercholesterolemic swine. J Thorac Cardiovasc Surg 2012;4:953-959.
117. Lee AJ, Flanagan PA, Rumley A, Fowkes FGR, Lowe GDO. Relationship between alcohol intake and tissue-plasminogen activator antigen and other hemostatic factors in the general population. Fibrinolysis 1995;9:49-54.
118. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions:etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 2001;4:260-273.
119. Lijnen HR. Role of fibrinolysis in obesity and thrombosis. Thromb Res 2009;123(Suppl 4):S46-S49.
120. Longaker MT, Whitby DJ, Adzick NS, Crombleholme TM, Langer JC, Duncan BW, Bradley SM, Stern R, Ferguson MW, Harrison MR. Studies in fetal wound healing, VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg 1990;1:63-68.
121. Loskutoff DJ, Samad F. The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 1998;18:1-6.
122. Lower AM, Hawthorn RJ, Ellis H, O'Brien F, Buchan S, Crowe AM. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. BJOG 2000;107:855-862.
123. Luijendijk RW, deLange DCD, Wauters CCAP, Hop WCJ, Duran JJ, Pailler JL, Camprodon BR, Holmdahl L, can Geldorp HJ, Jeekel J. Foreign material in postoperative adhesions. Ann Surg 1996;223:242-248.
124. Lundgren CH, Brown SL, Nordt TK, Sobel BE, Fujii S. Elaboration of type-1 plasminogen activator inhibitor from adipocytes: a potential pathogenetic link between obesity and cardiovascular disease. Circulation 1996;93:106-110.
125. Manassa EH, Hertl CH, Olbrisch RR. Wound healing problems in smokers and nonsmokers after 132 abdominoplasties. Plast Reconstr Surg 2003;111:2082-2087.
126. Mansfield MW, Heywood DM, Grant PJ. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation 1996;94:2171-2176.
127. Mansfield MW, Stickland MH, Grant PJ. PAI-1 concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations. Thromb Haemost 1997;77:357-361.
128. Margenthaler JA, Longo WE, Virgo KS, Johnson FE, Grossmann EM, Schifftner TL, Henderson WG, Khuri SF. Risk factors for adverse outcomes following surgery for small bowel obstruction. Ann Surg 2006;4:456-464.
129. McConnell MV, Vavouranakis I, Wu LL, Vaughan DE, Ridker PM. Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk. Am J Cardiol 1997;80:1226-1228.
130. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987;2:986-988.
131. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DR, Murphy-Sheehy PM, Lipinksa I, D'Agostino RB, Wilson PW. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study. JAMA 2000;283:221-228.
132. Menzies D. Postoperative adhesions: their treatment and relevance in clinical practice. Ann R Coll Surg Engl 1993;75:147-153.
133. Milewski L, Barcz E, Dziunycz P, Radomski D, Kaminski P, Roszkowski PI, Korczak-Kowalaska G, Malejczyk J. Association of leptin with inflammatory cytokines and lymphocyte subpopulations in peritoneal fluid of patients with endometriosis. J Reprod Immunol 2008;79:111-117.
134. Milingos S, Kallipolitis G, Loutradis D, Liapi A, Mavrommatis K, Drakakis D, Michalas S. Adhesions: laparoscopic surgery versus laparotomy. Ann N Y Acad Sci 2000; 900:272-285.
135. Modrau II, Iversen LL, Thorlacius-Ussing OO. Haemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery. Thromb Res 2001;104:309-315.
136. Molinas CR, Mynbaev O, Pauwels A, Novak P, Koninckx PR. Peritoneal mesothelial hypoxia during pneumoperitoneum is a cofactor in adhesion formation in a laparoscopic mouse model. Fertil Steril 2001;3:560-567.
137. Monk BJ, Fowler JM, Burger RA, McGonigle KF, Eddy GL, Berman ML, Montz FJ. Expanded polytetrafluoroethylene is an effective barrier in preventing pelvic adhesions after radical surgery for ovarian cancer. Int J Gynecol Cancer 1998; 8:403-408.
138. Montz FJ, Monk BJ, Lacy SM. The gore-tex surgical membrane: effectiveness as a barrier to inhibit postradical pelvic surgery adhesions in a porcine model. Gynecol Oncol 1992;3:290-293.
139. Morris PJ, Packianathan CI, Van Blerk CJ, Finer N. Moderate exercise and fibrinolytic potential in obese sedentary men with metabolic syndrome. Obes Res 2003; 11:1333-1338.
140. Mukamal KJ, Jadhav PP, D'Agostino RB, Massaro JM, Mittleman MA, Lipinska I, Sutherland PA, Matheney T, Levy D, Wilson PW et al. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation 2001; 104:1367-1373.
141. Murphy LJ, Ghahary A. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 1990;3:443-453.
142. Murphy AA, Kettel LM, Morales AJ, Yen SSC. Regression of uterine leiomyomata in response to the antiprogesterone RU486. J Clin Endocrinol Metab 1993;76:513-517.
143. Mutsaers SE, Wilkosz S. Structure and function of mesothelial cells. Cancer Treat Res 2007;134:1-19.
144. Newby DE, McLead AL, Uren NG, Flint L, Ludlam CA, Webb DJ, Fox KA, Boon NA. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation 2001;103:1936-1941.
145. Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE, Fagoaga OR. Influence of obesity on immune function. J Am Diet Assoc 1999;99:294-299.
146. Nieuwenhuijzen M, Reijen MM, Kuijpers JH, van Goor H. Small bowel obstruction after total or subtotal colectomy: a 10-year retrospective review. Br J Surg 1998; 85:1242-1245.
147. Nilsson TK, Sundell IB, Hellsten G, Hallmans G. Reduced plasminogen activator inhibitor activity in high consumers of fruits, vegetables, and root vegetables. J Intern Med 1990;227:267-271.
148. Norris LA, Brosnan J, Bonnar J, Conard J, Kluft C, Hellgren M. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/dydrogesterone and estradiol (2 mg)/trimegestone. Thromb Haemost 2008;2:253-260.
149. Ott DE. Laparoscopy and tribology: the effect of laparoscopic gas on peritoneal fluid. J Am Assoc Gynecol Laparosc 2001;1:117-123.
150. Pankow JS, Folson AR, Province MA, Rao DC, Williams RR, Eckfeldt J, Sellers TA. Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI family heart study. Arterioscler Thromb Vasc Biol 1998; 10:1559-1567.
151. Parker MC, Ellis H, Moran BJ, Thompson JN, Wilson MS, Menzies D, McGuire A, Lower AM, Hawthorn RJ, O'Briena F. Postoperative adhesions: ten-year follow up of 12 584 patients undergoing lower abdominal surgery. Dis Colon Rectum 2001; 44:822-829.
152. Parker MC, Wilson MS, Menzies D, Sunderland G, Clark DN, Knight AD, Crowe AM. The SCAR-3 study:5-year adhesion-related readmission risk following lower abdominal surgical procedures. Colorectal Dis 2005;6:551-558.
153. Parker MC, Wilson MS, van Goor H, Moran BJ, Jeekel J, Duron JJ, Menzies D, Wexner SD, Ellis H. Adhesions and colorectal surgery-call for action. Colorectal Dis 2007;9(Suppl 2):66-72.
154. Peetz D, Victor A, Adams P, Erbes H, Hafner G, Lackner KJ, Hoehler T. Genetic and environmental influences on the fibrinolytic system: a twin study. Thromb Haemost 2004;92:344-351.
155. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004;2:97-110.
156. Pellegrini N, Pareti FI, Stabile F, Brusamolino A, Simonetti P. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr 1996;50:209-213.
157. Peters AA, Trimbos-Kemper GC, Admiraal C, Trimbos JB, Hermans J. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynaecol 1992;99:59-62.
158. Petersen CM. Alpha 2-macroglobulin and pregnancy zone protein. Serum levels, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology. Dan Med Bull 1993;4:409-446.
159. Połać I, Borowiecka M, Wilamowska A, Nowak P. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. Gynecol Endocrinol 2013;2:165-168.
160. Potter van Loon BJ, Kluft C, Radder JK, Blankenstein MA, Meinders AE. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism 1993;42:945-949.
161. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB, Myofibroblasts I. Paracrine cells important in health and disease. Am J Physiol 1999;277(1 Pt 1):C1-C9.
162. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006; 24:33-50.
163. Procházková J, Dhaifallah I, Mechurová A, Pilka R, Simetka O, Slavik L, Ulehlova J, Lubusky M, Prochazka M. Monitoring of endothelial activation markers during physiological pregnancy. Ceska Gynekol 2010;2:92-100.
164. Pucciarelli S, Codello L, Rosato A, Del Bianco P, Vecchiato G, Lise M. Effect of antiadhesive agents on peritoneal carcinomatosis in an experimental model. Br J Surg 2003;90:66-71.
165. Raftery AT. Regeneration of parietal and visceral peritoneum in the immature animal: a light and electron microscopical study. Br J Surg 1973;60:969-975.
166. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-816.
167. Raikkonen K, Lassila R, Keltikangas-Jarvinen L, Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol 1996;16:363-367.
168. Raynaud E, Pérez-Martin A, Brun J-P, Aissa-Benhaddad A, Fédou C, Mericer J. Relationship between fibrinogen and insulin resistance. Artherosclerosis 2000; 150:365-370.
169. Reed T, Tracy RP, Fabsitz RR. Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI Twin Study. Clin Genet 1994;45:71-77.
170. Reed KL, Heydrick SJ, Aarons CB, Prushik S, Gower AC, Stucchi AF, Becker JM. A neurokinin-1 receptor antagonist that reduces intra-abdominal adhesion formation decreases oxidative stress in the peritoneum. Am J Physiol Gastrointest Liver Physiol 2007;3:G544-G551.
171. Rehman KS, Yin S, Mayhew BA, Word RA, Rainey WE. Human myometrial adaptation to pregnancy: CDNA microarray gene expression profiling of myometrium from non-pregnant and pregnant women. Mol Hum Reprod 2003;11:681-700.
172. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992;11:237-248.
173. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994;272:929-933.
174. Rizk NN, Saed GM, Diamond MP. Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-i receptors in human normal peritoneal and adhesion fibroblasts. Fertil Steril 2006;86(4 Suppl):1217-1222.
175. Rout UK, Saed GM, Diamond MP. Expression pattern and regulation of genes differ between fibroblasts of adhesion and normal human peritoneum. Reprod Biol Endocrinol 2005;1:1.
176. Rowlatt U. Intrauterine wound healing in a 20 week human fetus. Virchows Arch A Pathol Anat Histol 1979;3:353-361.
177. Saed GM, Diamond MP. Hypoxia-induced irreversible up-regulation of type I collagen and transforming growth factor-beta1 in human peritoneal fibroblasts. Fertil Steril 2002;1:144-147.
178. Saed GM, Diamond MP. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts. Fertil Steril 2003;1:164-168.
179. Saed GM, Diamond MP. Molecular characterization of postoperative adhesions: the adhesion phenotype. J Am Assoc Gynecol Laparosc 2004;3:307-314.
180. Saed GM, Diamond MP. Effects of interferon-gamma reverse hypoxia-stimulated extracellular matrix expression in human peritoneal and adhesion fibroblasts. Fertil Steril 2006;85(Suppl 1):1300-1305.
181. Saed GM, Collins KL, Diamond MP. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia. Am J Reprod Immunol 2002;6:387-393.
182. Saed GM, Munkarah AR, Diamond MP. Cyclooxygenase-2 is expressed in human fibroblasts isolated from intraperitoneal adhesions but not from normal peritoneal tissues. Fertil Steril 2003;6:1404-1408.
183. Saed GM, Kruger M, Diamond MP. Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel. Wound Repair Regen 2004; 12:557-564.
184. Samarrae WA, Truswell AS. Short-term effect of coffee on blood fibrinolytic activity in healthy adults. Atherosclerosis 1977;26:255-260.
185. Sasaki T, Shimura H, Tanaka T, Nakashima K, Matsuo K, Ikeda S. Protection of trocar sites from gallbladder cancer implantation by sodium hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm) in a murine model [corrected]. Surg Endosc 2004;18:246-251. Erratum in: Surg Endosc 2004; 18:1156.
186. Sato Y, Kaji M, Metoki N, Yoshida H, Satoh K. Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents. J Neurol Sci 2003;212:55-58.
187. Sattar N, Greer IA, Rumley A, Stewart G, Shepherd J, Packard CJ, Lower GD. A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy. Thromb Haemost 1999;81:71-75.
188. Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 1993;13:886-891.
189. Schmidt EB, Varming K, Ernst E, Madsen P, Dyerberg J. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost 1990;63:1-5.
190. Selman M, Pardo A. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am J Respir Crit Care Med 2014;189:1161-1172.
191. Sener SF, Imperato JP, Blum MD, Ignatoff JM, Soper TG, Winchester DP, Meiselman M. Technique and complications of reconstruction of the pelvic floor with polyglactin mesh. Surg Gynecol Obstet 1989;6:475-480.
192. Sharma K. Obesity, oxidative stress, and fibrosis in chronic kidney disease. Kidney Int Suppl (2011) 2014;4:113-117.
193. Shavell VI, Fletcher NM, Jiang ZL, Saed GM, Diamond MP. Uncoupling oxidative phosphorylation with 2,4-dinitrophenol promotes development of the adhesion phenotype. Fertil Steril 2012;97:729-733.
194. Sherry S, Lindemeyer RI, Fletcher AP, Alkjaersig N. Studies on enhanced fibrinolytic activity in man. J Clin Invest 1959;38:810-822.
195. Shimomura M, Hinoi T, Ikeda S, Adachi T, Kawaguchi Y, Tokunaga M, Sasada T, Egi H, Tanabe K, Okajima M et al. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery. Surgery 2013;3:344-356.
196. Siegbahn A, Ruusuvaara L. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Thromb Haemost 1988;60:361-364.
197. Sikirica V, Bapat B, Candrilli SD, Davis KL, Wilson M, Johns A. The inpatient burden of abdominal and gynecological adhesiolysis in the US. BMC Surg 2011;11:13.
198. Sikkink CJ, Postma VA, Reijnen MM, De Man B, Bleichrodt RP, Van Goor H. Hyaluronan-based antiadhesive membrane has no major effect on intraperitoneal growth of colonic tumour cells. Eur Surg Res 2004;36:123-128.
199. Simpson AJ, Gray RS, Moore NR, Booth NA. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. Br J Haematol 1997;97:208-213.
200. Souto JC, Almasy L, Blangero J, Stone W, Borrell M, Urrutia T, Mateo J, Fontcuberta J. Genetic regulation of plasma levels of vitamin K-dependent proteins involved in hemostasis: results from the GAIT Project. Genetic Analysis of Idiopathic Thrombophilia. Thromb Haemost 2001;85:88-92.
201. Souza AM, Rogers MS, Wang CC, Yuen PM, Ng PS. Comparison of peritoneal oxidative stress during laparoscopy and laparotomy. J Am Assoc Gynecol Laparosc 2003; 10:65-74.
202. Steptoe A, Kunz-Ebrecht S, Owen N, Feldman PJ, Rumley A, Lowe GD, Marmot M. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom Med 2003;65:137-144.
203. Stocker LJ, Glazebrook JE, Cheong YC. Are skin scar characteristics associated with the degree of pelvic adhesions at laparoscopy? Fertil Steril 2014;101:501-505.
204. Stones W, Cheong YC, Howard FM. Interventions for treating chronic pelvic pain in women. Cochrane Database Syst Rev 2005;2:CD000387.
205. Swank DJ. A prospective analysis of predictive factors on the results of laparoscopic adhesiolysis in patients with chronic abdominal pain. Surg Laparosc Endosc Percutan Tech 2003;2:88-94.
206. Swank DJ, Swank-Bordewijk SC, Hop WC, van Erp WF, Janssen IM, Bonjer HJ. Laparoscopic adhesiolysis in patients with chronic abdominal pain: a blinded randomised controlled multi-centre trial. Lancet 2003;361:1247-1251.
207. Szecsi PB, Jørgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010;4:718-727.
208. Taskin O, Buhur A, Birincioglu M, Burak F, Atmaca R, Yilmaz I, Wheeler JM. The effects of duration of CO2 insufflation and irrigation on peritoneal microcirculation assessed by free radical scavengers and total glutathion levels during operative laparoscopy. J Am Assoc Gynecol Laparosc 1998;5:129-133.
209. Taskin O, Sadik S, Onoglu A, Gokdeniz R, Yilmaz I, Burak F, Wheeler JM. Adhesion formation after microlaparoscopic and laparoscopic ovarian coagulation for polycystic ovary disease. J Am Assoc Gynecol Laparosc 1999;6:159-163.
210. ten Broek RPG, Issa Y, van Santbrink EJP, Bouvy ND, Kruitwagen RFPM, Jeekel J, Bakkum EA, Rovers MM, van Goor H. Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis. BMJ 2013;347:f5588.
211. ten Broek RP, Stommel MW, Strik C, van Laarhoven CJ, Keus F, van Goor H. Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet 2014;383:48-59.
212. Tewfik HH, Gruber H, Tewfik FA, Lifshitz SG. Intraperitoneal distribution of 32p-chromic phosphate suspension in the dog. Int J Radiat Oncol Biol Phys 1979; 10:1907-1913.
213. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and nonsmokers. Thromb Haemost 1991;65:487-490.
214. Thrall G, Lane D, Carroll D, Lip GY. A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis, and platelet reactivity: implications for the pathogenesis of acute coronary syndromes. Thromb Res 2007;120:819-847.
215. Trimbos-Kemper TC, Trimbos JB, van Hall EV. Adhesion formation after tubal surgery:results of the eight day laparoscopy in 188 patients. Fertil Steril 1985;43:395-400.
216. Urano T, Cho M, Takahashi S, Sumiyoshi K, Nakamura M, Mori T, Takada Y, Takada A. Changes of parameters in fibrinolytic system caused by mental stress. Thromb Res 1990;60:501-507.
217. van de WA, van Golde PM, Kraaijenhagen RJ, dem Borne PA, Bouma BN, Hart HC. Acute inhibitory effect of alcohol on fibrinolysis. Eur J Clin Invest 2001;31:164-170.
218. Veenstra J, Kluft C, Ockhuizen TH, vd Pol H, Wedel M, Schaafsma G. Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor. Thromb Haemost 1990;63:345-348.
219. Veldhuijzen van Zanten JJCS, Ring C, Burns VE, Edwards KM, Drayson M, Carroll D. Mental stress-induced hemoconcentration: sex differences and mechanisms. Psychophysiology 2004;41:541-551.
220. von Känel R, Dimsdale JE. Fibrin D-dimer: a marker of psychosocial distress and its implications for research in stress-related coronary artery disease. Clin Cardiol 2003;26:164-168.
221. von Känel R, Dimsdale JE, Adler KA, Patterson TL, Mills PJ, Grant I. Effects of depressive symptoms and anxiety on hemostatic responses to acute mental stress and recovery in the elderly. Psychiatry Res 2004;126:253-264.
222. Vrijkotte TG, van Doornen LJ, De Geus EJ. Work stress and metabolic and hemostatic risk factors. Psychosom Med 1999;61:796-805.
223. Wamala SP, Murray MA, Horsten M, Eriksson M, Schenck-Gustafsson K, Hamsten A, Silveira A, Orth-Gomer K. Socioeconomic status and determinants of hemostatic function in healthy women. Arterioscler Thromb Vasc Biol 1999; 19:485-492.
224. Weibel MA, Majno G. Peritoneal adhesions and their relation to abdominal surgery. A postmortem study. Am J Surg 1973;3:345-353.
225. Wheeless CR, Julian CG, Burnett LS, Dorsey JH. Synthetic pelvic floor sling to decrease small bowel complications after total exenteration. Obstet Gynecol 1971;5:779-783.
226. White JC, Jiang ZL, Diamond MP, Saed GM. Macrophages induce the adhesion phenotype in normal peritoneal fibroblasts. Fertil Steril 2011;96:758-763.e3.
227. Wiczyk HP, Grow DR, Adams LA, O'Shea DL, Reece MT. Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors. Fertil Steril 1998; 3:511-516.
228. Wieser F, Tempfer C, Schneeberger C, van Trotsenburg M, Huber J, Wenzl R. Interleukin-1 receptor antagonist polymorphism in women with peritoneal adhesions. BJOG 2002;109:1298-1300.
229. Wilkins BM, Spitz L. Incidence of postoperative adhesion obstruction following neonatal laparotomy. Br J Surg 1986;73:762-764.
230. Wilson JA, Clark JJ. Obesity: impediment to postsurgical wound healing. Adv Skin Wound Care 2004;17:426-435.
231. Wojta J, Kirchheimer JC, Peska MG, Binder BR. Effect of caffeine ingestion on plasma fibrinolytic potential. Thromb Haemost 1988;59:337-338.
232. Wolf JP, Hsiu JG, Anderson TL, Ulmann A, Baulieu EE, Hodgen GD. Noncompetitive antiestrogenic effect of RU486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil Steril 1989;52:1055-1060.
233. Womack CJ, Ivey FM, Gardner AW, Macko RF. Fibrinolytic response to acute exercise in patients with peripheral arterial disease. Med Sci Sports Exerc 2001; 33:214-219.
234. Yarnell JW, Sweetnam PM, Rumley A, Lowe GD. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vasc Biol 2000; 20:271-279.
235. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Artherosclerosis 2000; 148:209-214.
236. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli VA. Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 1992; 18:104-116.
237. Zhao J, Randive R, Stewart JA. Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart. World J Diabetes 2014;5:860-867.